APA (7th ed.) Citation

Y, W., J, L., W, Z., S, L., L, M., Z, L., . . . J, Y. (2023). Extending the dosing interval of COVID-19 vaccination leads to higher rates of seroconversion in people living with HIV. Frontiers in immunology, 14, 1152695. https://doi.org/10.3389/fimmu.2023.1152695

Chicago Style (17th ed.) Citation

Y, Wang, et al. "Extending the Dosing Interval of COVID-19 Vaccination Leads to Higher Rates of Seroconversion in People Living with HIV." Frontiers in Immunology 14 (2023): 1152695. https://doi.org/10.3389/fimmu.2023.1152695.

MLA (9th ed.) Citation

Y, Wang, et al. "Extending the Dosing Interval of COVID-19 Vaccination Leads to Higher Rates of Seroconversion in People Living with HIV." Frontiers in Immunology, vol. 14, 2023, p. 1152695, https://doi.org/10.3389/fimmu.2023.1152695.